Zoetis Q3 revenue $2.4B (+11%); adjusted EPS $1.58; FY guidance raised

Zoetis Inc.

2024-Q3 EPS reported $4.18 revenue$6,939,000,000

Revenue $2.4B, +11% reported (+14% operational); GAAP EPS $1.50 (+16% YoY).
Adjusted net income $716M, adjusted EPS $1.58 (+16% reported, +17% operational).
U.S. segment revenue $1.3B (+15%) led by mAbs (Librela, Solensia) and Simparica Trio.
International segment revenue $1.0B (+7% reported, +13% operational) with broad product strength.
FY2024 guidance raised: revenue $9.20-9.30B, adjusted EPS $5.86-5.92, operational growth 10-11%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.